Document is current
Any future updates will be listed below
-
Authors
Wahlen, Sarah
Breuing, Jessica
Becker, Monika
Bühn, Stefanie
Hauprich, Julia
Könsgen, Nadja
Meyer, Nora
Blödt, Susanne
Carl, Günther
Follmann, Markus
Frenz, Stefanie
Langer, Thomas
Nothacker, Monika
Schaefer, Corinna
Pieper, Dawid
-
Funding
Funding for this research was provided by:
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 7 June 2023
Accepted: 23 January 2024
First Online: 4 March 2024
Declarations
:
: This study was approved by the University Witten/Herdecke Ethics Committee (160/2021). All procedures were performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all the participants.
: Not applicable.
: MB was involved in the development of patient versions of oncology in Germany. SBl and MN are representatives of the AWMF, which receives constant financial support from the GGPO and is involved in methodological counselling for CPGs in oncology and other CPGs. MF is a representative publisher of patient versions in oncology in Germany and is involved in the methodological counselling of CPGs and patient versions in oncology. TL is a representative publisher of patient versions of oncology in Germany. CS was involved in the development of patient versions in oncology in Germany until 2019 and is responsible for the development of patient versions of the National Program for Disease Management Guidelines (NDMG) and their methodological refinement. All other authors declare no conflict of interest.
